Luke W. Guddat
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 38
- Tuberculosis Research and Epidemiology 16
- Molecular Biology top 1%
- Biochemical and Molecular Research 83
- Pollution top 1%
- Molecular Medicine top 2%
- Biochemistry top 1%
- Biochemical Acid Research Studies 14
-
- Enzyme Structure and Function 33
-
- Pneumocystis jirovecii pneumonia detection and treatment 18
-
- Monoclonal and Polyclonal Antibodies Research 14
-
- Fungal Plant Pathogen Control 14
Luke W. Guddat
204 papers receiving 7.6k citations
Peers
Comparison fields: 5 of 144
- Infectious Diseases 1.6k
- Molecular Biology 4.6k
- Pollution 641
- Molecular Medicine 241
- Biochemistry 349
Countries citing papers authored by Luke W. Guddat
This map shows the geographic impact of Luke W. Guddat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke W. Guddat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke W. Guddat more than expected).
Fields of papers citing papers by Luke W. Guddat
This network shows the impact of papers produced by Luke W. Guddat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke W. Guddat. The network helps show where Luke W. Guddat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luke W. Guddat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 106 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 29 | |
| 11 | 2021 | 22 | |
| 12 | 2020 | 54 | |
| 13 | 2020 | 27 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 8 | |
| 16 | 2019 | 13 | |
| 17 | 2018 | 138 | |
| 18 | 2018 | 6 | |
| 19 | 2017 | 19 | |
| 20 | 2017 | 18 |
About Luke W. Guddat
Luke W. Guddat is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine, having authored 211 papers that have together received 7.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (83 papers), HIV/AIDS drug development and treatment (38 papers), Enzyme Structure and Function (33 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers), Tuberculosis Research and Epidemiology (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Biochemical Acid Research Studies (14 papers) and Fungal Plant Pathogen Control (14 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Molecular Biology (4.6k citations) and Pollution (641 citations). Luke W. Guddat has collaborated with scholars based in Australia, China and Czechia. Frequent co-authors include Ronald G. Duggleby, Gerhard Schenk, Siew Siew Pang, Jennifer A. McCourt, John de Jersey, Dianne T. Keough, Lawrence R. Gahan, Nataša Mitić, Allen B. Edmundson and Jennifer L. Martin. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.